Abu NanaAccounting Specialist, New Ventures
Abu conducts the day-to-day accounting and finance activities for several new ventures within MaRS Innovation, including Encycle Therapeutics, QD Solar, Vasomune Therapeutics, Bright Angel Therapeutics and Fibrocor Therapeutics. He manages their financial reporting and compliance with GAAP (Generally Accepted Accounting Principles).
Prior to joining MaRS Innovation, Abu was an accountant at MaRS Discovery District, where he managed cash-flow forecasting and assisted in reconciling internal company accounts. He also worked with management and co-workers to improve financial policies and procedures within the organization.
Abu holds a BComm from Ryerson University and earned his Chartered Professional Accounting (CPA) designation while working at MaRS Discovery District.